Effect of Psychotherapy on Health Care Utilization in Children With Inflammatory Bowel Disease and Depression

Divya Keerthy1, Ada Youk, Arvind I Srinath

  • 1*University of Pittsburgh School of Medicine †Department of Biostatistics, University of Pittsburgh ‡Department of Pediatrics, Children's Hospital of Pittsburgh of UPMC §Departments of Psychiatry and Pediatrics, University of Michigan Health System ||Department of Psychiatry, Boston Children's Hospital ¶Division of Gastroenterology, Hepatology, & Nutrition, Boston Children's Hospital #Division of Pediatric Gastroenterology, Children's Hospital of Pittsburgh of UPMC **Department of Psychiatry, University of Pittsburgh.

Insights

Treating depression in pediatric inflammatory bowel disease (IBD) patients with psychotherapy significantly reduced healthcare use. This highlights the importance of screening for depression and offering psychotherapy as an adjunctive treatment for IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Child and Adolescent Psychiatry
  • Health Services Research

Background:

  • Pediatric patients with inflammatory bowel disease (IBD) face a higher risk of depression.
  • Depression in pediatric IBD can negatively impact illness behaviors and healthcare resource utilization.

Purpose of the Study:

  • To investigate the impact of psychotherapy on healthcare resource utilization in depressed pediatric IBD patients.
  • To compare healthcare utilization rates one year before and after psychotherapy intervention.

Main Methods:

  • A multicenter randomized controlled trial involving 217 pediatric patients (ages 9-17) with IBD and depression.
  • 70 subjects with available utilization data underwent 3 months of psychotherapy.
  • Analysis compared healthcare utilization (hospitalizations, visits, procedures) 12 months pre- and post-psychotherapy.

Main Results:

  • All measured healthcare utilization significantly decreased post-psychotherapy (P < 0.01).
  • Reductions were observed in hospitalization frequency, inpatient days, outpatient GI visits, ER visits, radiological exams, and endoscopies.
  • The study included patients with Crohn's disease (CD) and ulcerative colitis (UC).

Conclusions:

  • Psychotherapy for comorbid depression in pediatric IBD patients is linked to reduced gastrointestinal-related healthcare utilization.
  • Screening for depression in pediatric IBD is crucial.
  • Psychotherapy may serve as an effective adjunctive treatment for this population.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
613
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
912
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
657